Smart Implants: The Devices Living Inside Patients and Sending Data Back

The pacemaker in the chest of a cardiac patient in Omaha can send data to their cardiologist's phone in real time. Not on a monthly basis after a clinic visit. Not after a device download at the office. Continuously, flagging any arrhythmia the moment it occurs. Medtronic's Micra transcatheter pacing system and Abbott's Gallant series both have this capability, and hundreds of thousands of patients in the United States are already living with connected implants of this kind.

This is not theoretical. The era of the connected body is already here.

Smart implants are broadly defined as any implantable device that can sense physiological data and transmit it externally. The category is older than people realize. Cochlear implants have had wireless programming capability for years. Insulin pumps can talk to continuous glucose monitors and adjust insulin delivery automatically. The newer generation of cardiac devices can monitor dozens of variables simultaneously and send alerts that allow clinicians to intervene before a patient is even aware something is wrong.

The clinical case for remote monitoring is strong. A 2021 study published in the European Heart Journal found that patients with heart failure who were monitored remotely through an implanted sensor had significantly lower rates of hospitalization than those receiving standard care. The device was detecting fluid buildup in the lungs up to two weeks before symptoms became severe, giving physicians time to adjust medications before a crisis developed.

The concept extends beyond cardiac care. Neural implants represent one of the most closely watched areas in medicine and technology right now. Neuralink received FDA approval for human trials in 2023 and implanted its first device in a patient in early 2024. The initial application is for patients with paralysis, with the goal of allowing them to control computers and external devices through thought. Synchron, a less prominent but more clinically focused competitor, had already implanted its stentrode device in several patients and published encouraging early data showing that locked-in patients could control digital interfaces with meaningful accuracy.

The questions that follow these devices are not purely technical. Security is one. Medical implants that communicate wirelessly are, in principle, vulnerable to interference. Researchers have demonstrated that some older cardiac device protocols had exploitable vulnerabilities, and while manufacturers have significantly improved security practices, the concern is not theoretical.

Privacy is another. A device that continuously monitors your physiology generates a remarkably intimate data stream. Who owns that data? Can an insurer request access? Can it be subpoenaed in court? Most patients implanted with connected devices have not thought carefully about these questions, and the legal frameworks that would answer them are still being written.

The trajectory of smart implants is toward greater capability, smaller form factors, and more conditions addressed. What will make or break public acceptance is not the technology itself but whether the institutions managing it can be trusted with something this personal.